- 同一論文・投稿 (to be publishedを含む)ごとのリストのため、新規公開エントリーより以前に公開されたエントリーも含まれている。
- カラムTitleは、To be publishedの投稿については仮置であり、ジャーナルからの公開時には変更されている可能性がある。
- カラムRelease Dateの"AUTH"は"編集処理済、登録者の確認・同意待ち"を意味し、"HPUB"は"論文発表待ち"を意味する。
- 2020年9月2日以前に公開された構造については、PDBj Web siteの新型コロナウイルスの構造情報 全エントリー, または, crisp_bioの過去記事「新型コロナウイルスのPDB公開構造一覧 - その６; その５; その４; その３; その２; その1」参照
- 2020-09-02日以後、PDBの更新に合わせて新規公開分を原則毎週水曜日に投稿
|
ID |
Title |
Release Date |
|
論文 |
Tortorici, M.A.,Beltramello, M.,Lempp, F.A.,Pinto, D.,Dang, H.V.,Rosen, L.E.,McCallum, M.,Bowen, J.,Minola, A.,Jaconi, S.,Zatta, F.,De Marco, A.,Guarino, B.,Bianchi, S.,Lauron, E.J.,Tucker, H.,Zhou, J.,Peter, A.,Havenar-Daughton, C.,Wojcechowskyj, J.A.,Case, J.B.,Chen, R.E.,Kaiser, H.,Montiel-Ruiz, M.,Meury, M.,Czudnochowski, N.,Spreafico, R.,Dillen, J.,Ng, C.,Sprugasci, N.,Culap, K.,Benigni, F.,Abdelnabi, R.,Foo, S.C.,Schmid, M.A.,Cameroni, E.,Riva, A.,Gabrieli, A.,Galli, M.,Pizzuto, M.S.,Neyts, J.,Diamond, M.S.,Virgin, H.W.,Snell, G.,Corti, D.,Fink, K.,Veesler, D. Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. |
|
|
An ultra-potent human neutralizing antibody locks the SARS-CoV-2 spike in the closed conformation |
2020-10-07 |
|
|
SARS-CoV-2 spike in complex with the S2M11 neutralizing antibody Fab fragment |
2020-10-07 |
|
|
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment (local refinement of the RBD and Fab variable domains) |
2020-10-07 |
|
|
SARS-CoV-2 spike in complex with the S2E12 neutralizing antibody Fab fragment |
2020-10-07 |
|
|
投稿 |
Bracken, C.J.,Wells, J.A. (QCRG Structural Biology Consortium) Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike |
To be publsihed |
|
SARS CoV2 Spike ectodomain with engineered trimerized VH binder |
2020-10-07 |
|
|
投稿 |
Lee, J.,Worrall, L.J.,Vuckovic, M.,Rosell, F.I.,Gentile, F.,Ton, A.T.,Caveney, N.A.,Ban, F.,Cherkasov, A.,Paetzel, M.,Strynadka, N.C.J. Crystallographic structure of wild-type SARS-CoV-2 Main Protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site |
To be published |
|
Structure of wild-type substrate free SARS-CoV-2 Mpro. |
2020-10-07 |
|
|
投稿 |
Lee, J.,Worrall, L.J.,Vuckovic, M.,Rosell, F.I.,Gentile, F.,Ton, A.T.,Caveney, N.A.,Ban, F.,Cherkasov, A.,Paetzel, M.,Strynadka, N.C.J. Crystallographic structure of wild-type SARS-CoV-2 Main Protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site |
To be published |
|
Acyl-enzyme intermediate structure of SARS-CoV-2 Mpro in complex with its C-terminal autoprocessing sequence. |
2020-10-07 |
|
|
投稿 |
Wu, K.-P.,Chen, S.-K.,Lu, Y.-C.,Huang, Y.-C.J.,Lee, M.-H. Crystal structure of SARS-CoV-2 Papain-like protease |
To be published |
|
Crystal structure of SARS-CoV-2 Papain-like protease C111S |
2020-10-07 |
|
|
投稿 |
Lee, J.,Worrall, L.J.,Vuckovic, M.,Rosell, F.I.,Gentile, F.,Ton, A.T.,Caveney, N.A.,Ban, F.,Cherkasov, A.,Paetzel, M.,Strynadka, N.C.J. Crystallographic structure of wild-type SARS-CoV-2 Main Protease acyl-enzyme intermediate with physiological C-terminal autoprocessing site |
To be published |
|
Product structure of SARS-CoV-2 Mpro C145A mutant in complex with its C-terminal autoprocessing sequence. |
2020-10-07 |
|
|
投稿 |
Qiao, J.X.,Zeng, R.,Li, Y.S.,Wang, Y.F.,Lei, J.,Yang, S.Y. Crystal structure of SARS-CoV-2 main protease in complex with MI-23 |
To be published |
|
Crystal structure of SARS-CoV-2 main protease in complex with MI-23 |
2020-10-07 |
コメント